The national drug regulator has recently granted the emergency use authorisation (EUA) to Bharat Biotech Covaxin for children belonging to the age group of 6 to 12 years. This will now rollout the need for vaccinating children under the age of 12. India has been consistently rolling out the Covid-19 vaccines based on epidemiological…
For emergency use, Covaxin has been given the approval to be utilized in 13 countries from January 31st as per WHO. Giving complete details about Covaxin, the minister of state ( MoS ) for health, Bharati Pravin Pawar in Lok Sabha said that covaxin has been granted by EUL Or emergency use listing by the…
In the current vaccination slots, people are being injected with either Covisheild or Covaxin. In the case of Covisheild, it has been accounted for over 85% of all the vaccination as per recent reports from the Governmental departments on May 13. Covisheild vaccination has recommended gap of 12 to 16 weeks. Whereas in the case…